June 20, 2017 / 12:14 PM / a month ago

BRIEF-Spherix announces definitive terms reached to acquire controlling interest in Hoth Therapeutics

1 Min Read

June 20 (Reuters) - Spherix Inc

* Spherix Inc. announces definitive terms reached to acquire controlling interest in Hoth therapeutics, a biopharmaceutical company developing its Biolexa platform to treat skin illness such as eczema.

* Spherix Inc - Believe investment is "an accretive value to our shareholders" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below